|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.770 USD | -1.67% |
|
-.--% | -31.92% |
| 20/07 | Nine stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 17/07 | 19 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Market Cap | 51Cr 5.41Cr 4.68Cr 4.37Cr 4.01Cr 7.54Cr 514.81Cr 7.66Cr 20Cr 258.03Cr 20Cr 20Cr 853.05Cr | P/E 2026 * |
-1.4x | P/E 2027 * | -2.02x |
|---|---|---|---|---|---|
| Enterprise Value | 41Cr 4.3Cr 3.72Cr 3.47Cr 3.19Cr 6Cr 409.37Cr 6.09Cr 16Cr 205.18Cr 16Cr 16Cr 678.33Cr | EV / Sales 2026 * |
21.5x | EV / Sales 2027 * | 13.4x |
| Free-Float |
70.1% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Orexo AB
| 1 day | -1.67% | ||
| 1 month | -11.50% | ||
| 3 months | -13.45% | ||
| 6 months | -31.92% | ||
| Current year | -31.92% |
| 1 month | 1.36 |  | 2.1 |
| Current year | 1.36 | | 2.65 |
| 1 year | 1.36 | | 4.05 |
| 3 years | 0.89 | | 4.05 |
| 5 years | 0.76 | | 4.13 |
| 10 years | 0.76 | | 9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nikolaj Sørensen
CEO | Chief Executive Officer | 54 | 05/02/2013 |
Fredrik Järrsten
DFI | Director of Finance/CFO | 59 | 01/09/2022 |
Jonas Savmarker
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 01/01/2002 | |
George Wilkinson
BRD | Director/Board Member | 70 | 11/04/2019 |
Christine Rankin
BRD | Director/Board Member | 62 | 01/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.67% | -.--% | - | - | 5.41Cr | |
| +0.80% | +1.38% | +61.85% | +22.70% | 32TCr | |
| 0.00% | +0.98% | +33.19% | -12.82% | 7.22TCr | |
| -0.30% | +25.59% | +64.29% | +134.67% | 1.17TCr | |
| +0.63% | +1.87% | -2.19% | -3.95% | 845.46Cr | |
| +2.28% | +8.10% | -14.26% | -14.00% | 474.51Cr | |
| +14.37% | +22.10% | +4.25% | +50.44% | 437.72Cr | |
| +3.60% | +9.66% | -28.04% | +8.36% | 426.38Cr | |
| -0.88% | +2.92% | +16.70% | +48.93% | 276.92Cr | |
| +4.26% | +0.31% | +1.17% | +0.23% | 225.61Cr | |
| Average | +2.32% | +8.20% | +15.22% | +26.06% | 4.76TCr | |
| Weighted average by Cap. | +0.82% | +0.31% | +52.88% | +19.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.9Cr 20.05L 17.34L 16.19L 14.86L 27.94L 19Cr 28.39L 74.57L 9.56Cr 75.28L 73.64L 32Cr | 2.75Cr 29.02L 25.1L 23.44L 21.5L 40.44L 28Cr 41.08L 1.08Cr 14Cr 1.09Cr 1.07Cr 46Cr |
| Net income | -38Cr -3.96Cr -3.42Cr -3.2Cr -2.93Cr -5.51Cr -376.58Cr -5.6Cr -15Cr -188.75Cr -15Cr -15Cr -624Cr | -27Cr -2.85Cr -2.47Cr -2.31Cr -2.12Cr -3.98Cr -271.64Cr -4.04Cr -11Cr -136.15Cr -11Cr -10Cr -450.11Cr |
| Net Debt | -10Cr -1.11Cr -95.83L -89.5L -82.1L -1.54Cr -105.44Cr -1.57Cr -4.12Cr -53Cr -4.16Cr -4.07Cr -174.72Cr | -14Cr -1.51Cr -1.31Cr -1.22Cr -1.12Cr -2.1Cr -143.6Cr -2.14Cr -5.61Cr -72Cr -5.67Cr -5.54Cr -237.95Cr |
Employees
61
Sector
Pharmaceuticals
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORX Stock
- ORXOY Stock
Select your edition
All financial news and data tailored to specific country editions
